Where does Xellia Pharmaceuticals ApS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Xellia Pharmaceuticals ApS ranks #11,518 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Xellia Pharmaceuticals ApS hold?

Xellia Pharmaceuticals ApS holds 27 US utility patents granted between 2015 and 2024, spanning 16 technology areas.

What is Xellia Pharmaceuticals ApS's Innovation Score?

Xellia Pharmaceuticals ApS has an Innovation Score of 38.5 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Xellia Pharmaceuticals ApS focus on?

Xellia Pharmaceuticals ApS's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 21 patents, ranking #933 of 6,058 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is Xellia Pharmaceuticals ApS's patent grant rate increasing or decreasing?

Xellia Pharmaceuticals ApS's recent grant velocity is +25% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Xellia Pharmaceuticals ApS's patents?

Xellia Pharmaceuticals ApS's patents average 16.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Xellia Pharmaceuticals ApS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Xellia Pharmaceuticals ApS

USPTO PatentsView assignee record - 27 granted patents across 16 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Xellia ranks #11,518 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 16 technology areas.

#11,518
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.5/100): 16.2
avg claims per patent: +25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11518 · Foreign Corporation #11,518 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 27 grants
UPPER-Q #11,518/49,997
PHOTO-FINISH Wave Computing
CPC-FOCUS A61P · 16 areas
INNOV-THIN 38.5/100
CLAIMS-RICH 16.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Wave Computing, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Xellia’s 38.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (30%) Velocity 3.1 pts (8%) Breadth 14.1 pts (37%) Claim depth 9.7 pts (25%)

Qualcomm Incorporated · highest

85
Carefusion 207 · near

38
Invoca · near

38
Wrap · near

38
Xellia Pharmaceutica… · this assignee

38
Thermo Electron LED · near

38
3D Lighting… · lowest

7

What this shows Xellia's Innovation Score is 38.5/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Xellia?

Each dot is one of Xellia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Xellia’s own 16.2 claims/patent is ABOVE the 7.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Xellia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Xellia's grants concentrate

Xellia Pharmaceuticals ApS is a focused PatentsView assignee: 16 CPC subclasses with 77.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2018. By volume, Xellia sits between Wave Computing, Inc. and Zapadoceska univerzita v Plzni.

Xellia's three-year grant acceleration

Xellia Pharmaceuticals ApS shows 6 grants in 2022–2024 against only 13 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Wave Computing

27
Wayne/Scott Fetzer

27
Worxsafe AB

27
Xconnect

27
Yokogawa Test & M…

27
Zettaset

27
Zhejiang NHU

27
Zapadoceska unive…

27
Xellia Pharmaceut… ◀

27

What this shows Xellia holds 27 patents at rank #11,514, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xellia

By rank, the assignees closest to #11,514 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Xellia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Xellia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Xellia ranks #933 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Invoca, Inc. 38 Wrap Technologies, Inc. 38 Carefusion 207, Inc. 38 Thermo Electron LED GmbH 38

Xellia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Xellia Pharmaceuticals ApS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	18.5%
2016	2	7.4%
2018	1	3.7%
2019	4	14.8%
2020	5	18.5%
2021	4	14.8%
2022	1	3.7%
2023	2	7.4%
2024	3	11.1%

Which technologies does Xellia Pharmaceuticals ApS patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 21

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 21

Y02A - Technologies FOR Adaptation TO Climate Change 10

C07K - Peptides 7

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Y10T - Technical Subjects Covered BY Former US Classification 1

C08B - POLYSACCHARIDES; Derivatives Thereof 1

C08L - Compositions OF Macromolecular Compounds 1

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

B01D - Separation 1

C22B - Production AND Refining OF Metals ; Pretreatment OF RAW Materials 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Xellia Pharmaceuticals ApS's patent record in context - here's where to go next.

Xellia Pharmaceuticals ApS's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 77.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #11,518 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Xellia Pharmaceuticals ApS against Wave Computing, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.